OncologyConsults




Colorectal CME
CME Activities

Considerations for Use of Immune Therapy to Treat Metastatic Colorectal Cancer CME Credits: 0.5
Colorectal cancer (CRC) is a leading cause of cancer-related deaths with poor 5-year survival rates for patients with metastatic disease.
Faculty: Dung T. Le, MD Expires: 5/31/2020


The Role of the Oncology Nurse in Effective AE and Toxicity Management in Patients with Metastatic and Refractory Colorectal Cancer CME Credits: 0.5
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in the United States, expected to cause approximately 50 630 deaths in 2018.
Faculty: Cara Wilt, RN, MSN, CRNP Expires: 10/29/2019


Integrating Tyrosine Kinase Inhibitors in Colorectal Cancer Treatment Algorithms: Considerations for NTRK Gene Fusion Targeted Therapy CME Credits: 0.5
In human cancers, gene fusions involving neurotrophic tyrosine receptor kinases (NTRKs) are known drivers of a wide variety of adult and pediatric solid tumors.
Faculty: Nilofer Azad, MD, and Christopher Jakubowski, MD Expires: 1/22/2021